Pedro Borrego

Baseline Susceptibility of Primary HIV-2 to Entry Inhibitors

Pedro Borrego, Rita Calado, José Maria Marcelino et al. · Antiviral Therapy · 2011 · 47 citations

A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus

Shengwen Xiong, Pedro Borrego, Xiaohui Ding et al. · Journal of Virology · 2016 · 44 citations · Full text

Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides

Verónica Briz, Daniel Sepúlveda‐Crespo, Ana Rita Diniz et al. · Nanoscale · 2015 · 39 citations

Proceedings of the Frontiers of Retrovirology Conference 2016

Irena Zurnic, Sylvia Hütter, Ute Lehmann et al. · Retrovirology · 2016 · 37 citations · Full text

Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System

J Félix, Valeska Andreozzi, Marta Soares et al. · Value in Health · 2011 · 35 citations

Nursing, Healthcare Value, Health Policy +13